4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase
US-2017001955-A1 · Jan 5, 2017 · US
Eastern Virginia Medical School was listed as an assignee on 1 patent publication in 2017.
| Metric | Value |
|---|---|
| Company | Eastern Virginia Medical School |
| Year | 2017 |
| Patents | 1 |
Representative publications for Eastern Virginia Medical School in 2017.
Most common classification codes for Eastern Virginia Medical School in 2017.
| CPC | Patents |
|---|---|
| A61P7/02 | 1 |
| C07C311/44 | 1 |
| C07D211/28 | 1 |
| C07D213/76 | 1 |
| C07D217/02 | 1 |
Navigate to parent entity pages.